157 related articles for article (PubMed ID: 30109252)
1. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
[TBL] [Abstract][Full Text] [Related]
2. FXR-Gankyrin axis is involved in development of pediatric liver cancer.
Valanejad L; Lewis K; Wright M; Jiang Y; D'Souza A; Karns R; Sheridan R; Gupta A; Bove K; Witte D; Geller J; Tiao G; Nelson DL; Timchenko L; Timchenko N
Carcinogenesis; 2017 Jul; 38(7):738-747. PubMed ID: 28535186
[TBL] [Abstract][Full Text] [Related]
3. Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin.
D'Souza AM; Cast A; Kumbaji M; Rivas M; Gulati R; Johnston M; Smithrud D; Geller J; Timchenko N
Front Pharmacol; 2021; 12():580722. PubMed ID: 33746747
[No Abstract] [Full Text] [Related]
4. RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner.
Lewis K; Valanejad L; Cast A; Wright M; Wei C; Iakova P; Stock L; Karns R; Timchenko L; Timchenko N
Mol Cell Biol; 2017 Aug; 37(16):. PubMed ID: 28559429
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
[TBL] [Abstract][Full Text] [Related]
6. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease.
Cast A; Kumbaji M; D'Souza A; Rodriguez K; Gupta A; Karns R; Timchenko L; Timchenko N
Hepatol Commun; 2019 Aug; 3(8):1036-1049. PubMed ID: 31388625
[TBL] [Abstract][Full Text] [Related]
7. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
[TBL] [Abstract][Full Text] [Related]
8. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.
Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY
Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393
[TBL] [Abstract][Full Text] [Related]
9. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
[TBL] [Abstract][Full Text] [Related]
10. The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.
Dong LW; Yang GZ; Pan YF; Chen Y; Tan YX; Dai RY; Ren YB; Fu J; Wang HY
Cell Res; 2011 Aug; 21(8):1248-61. PubMed ID: 21691299
[TBL] [Abstract][Full Text] [Related]
11. C/EBPα-dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer.
Cast A; Valanejad L; Wright M; Nguyen P; Gupta A; Zhu L; Shin S; Timchenko N
Hepatology; 2018 May; 67(5):1857-1871. PubMed ID: 29159818
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Zhang S; Nguyen LH; Zhou K; Tu HC; Sehgal A; Nassour I; Li L; Gopal P; Goodman J; Singal AG; Yopp A; Zhang Y; Siegwart DJ; Zhu H
Gastroenterology; 2018 Apr; 154(5):1421-1434. PubMed ID: 29274368
[TBL] [Abstract][Full Text] [Related]
13. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma.
Ninomiya T; Hayashi Y; Saijoh K; Ohta K; Yoon S; Nakabayashi H; Tamaoki T; Kasuga M; Itoh H
J Hepatol; 1996 Oct; 25(4):445-53. PubMed ID: 8912143
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice.
Zhao J; Adams A; Roberts B; O'Neil M; Vittal A; Schmitt T; Kumer S; Cox J; Li Z; Weinman SA; Tikhanovich I
Hepatology; 2018 Mar; 67(3):1109-1126. PubMed ID: 29023917
[TBL] [Abstract][Full Text] [Related]
15. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
16. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.
Vacca M; Murzilli S; Salvatore L; Di Tullio G; D'Orazio A; Lo Sasso G; Graziano G; Pinzani M; Chieppa M; Mariani-Costantini R; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1518-1529.e3. PubMed ID: 23462179
[TBL] [Abstract][Full Text] [Related]
17. Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments.
Hong IH; Lewis K; Iakova P; Jin J; Sullivan E; Jawanmardi N; Timchenko L; Timchenko N
J Biol Chem; 2014 Jan; 289(2):1106-18. PubMed ID: 24273171
[TBL] [Abstract][Full Text] [Related]
18. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.
Fu J; Chen Y; Cao J; Luo T; Qian YW; Yang W; Ren YB; Su B; Cao GW; Yang Y; Yan YQ; Shen F; Wu MC; Feng GS; Wang HY
Hepatology; 2011 Jan; 53(1):181-92. PubMed ID: 21254169
[TBL] [Abstract][Full Text] [Related]
19. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.
Wree A; Johnson CD; Font-Burgada J; Eguchi A; Povero D; Karin M; Feldstein AE
Cell Death Differ; 2015 Dec; 22(12):1985-94. PubMed ID: 25909884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
